Morgan Stanley’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,000
| Closed | -$6.08K | – | 8045 |
|
|
2023
Q4 | $6.08K | Buy |
2,000
+1,000
| +100% | +$3.04K | ﹤0.01% | 6955 |
|
|
2023
Q3 | $2.84K | Sell |
1,000
-4,972
| -83% | -$14.1K | ﹤0.01% | 7048 |
|
|
2023
Q2 | $15.5K | Sell |
5,972
-119,231
| -95% | -$310K | ﹤0.01% | 6647 |
|
|
2023
Q1 | $228K | Buy |
125,203
+94,931
| +314% | +$173K | ﹤0.01% | 5657 |
|
|
2022
Q4 | $49.9K | Sell |
30,272
-39,062
| -56% | -$64.5K | ﹤0.01% | 6293 |
|
|
2022
Q3 | $133K | Sell |
69,334
-146,039
| -68% | -$280K | ﹤0.01% | 5933 |
|
|
2022
Q2 | $645K | Buy |
215,373
+56,023
| +35% | +$168K | ﹤0.01% | 5285 |
|
|
2022
Q1 | $600K | Buy |
159,350
+72,159
| +83% | +$272K | ﹤0.01% | 5298 |
|
|
2021
Q4 | $992K | Buy |
87,191
+84,002
| +2,634% | +$956K | ﹤0.01% | 5070 |
|
|
2021
Q3 | $56K | Buy |
3,189
+3,119
| +4,456% | +$54.8K | ﹤0.01% | 6669 |
|
|
2021
Q2 | $1K | Buy |
+70
| New | +$1K | ﹤0.01% | 7653 |
|